Adverts

Open Access Articles- Top Results for Girentuximab

Girentuximab

</th></tr>
Girentuximab?
Monoclonal antibody
Type Whole antibody
Source Chimeric
Target CA-IX
Clinical data
Trade names Rencarex
Identifiers
916138-87-9 7pxN
None
UNII 539B57DFJF 7pxY
Chemical data
Formula C6460H10006N1718O2018S48
146.5 kDa
 14pxN (what is this?)  (verify)

Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.[1]

Girentuximab was developed by Wilex AG.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Girentuximab" (PDF). American Medical Association. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.